跳至主要内容
临床试验/NL-OMON53099
NL-OMON53099招募中不适用

Identifying subgroups with High cArdiovascular Risk in Breast cancer survivORs (HARBOR) - HARBOR

Antoni van Leeuwenhoek Ziekenhuis0 个研究点目标入组 628 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
628

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - early invasive BC (TNM stage I - III);
  • - diagnosed and/or treated in the AVL or UMCG;
  • - treated 5 - 7 years or 10 - 12 years ago;
  • - aged 40-50 years at time of therapy;
  • - signed written informed consent.

排除标准

  • - history of RT or CT unrelated to BC;
  • - currently under treatment for BC recurrence or second malignancy (including
  • contralateral BC) other than non-melanomatous skin cancer or curatively treated
  • carcinoma in situ of the cervix;
  • - history of cardiac disease (CHF, acute coronary syndrome, coronary
  • revascularization procedure, symptomatic valvular dysfunction, cardiomyopathy
  • or congenital heart defect) before diagnosis and treatment for BC;
  • - mental disability or psychological condition potentially hampering compliance
  • with the study protocol;
  • - insufficient understanding of the Dutch language.

研究者

发起方
Antoni van Leeuwenhoek Ziekenhuis

相似试验